Host-derived Spi6 provides granzyme B-independent protection of intestinal epithelial cells in murine GVHD

Graft-versus-host disease (GVHD) is a serious complication after allogeneic hematopoietic cell transplantation (allo-HCT) that limits the therapeutic potential of this treatment. Host antigen-presenting cells (APCs) play a vital role in activating donor T cells which subsequently use granzyme B (GzmB) and other cytotoxic molecules to damage host normal tissues. Serine protease inhibitor 6 (Spi6), known as the sole endogenous inhibitor of GzmB, has been implicated in protecting T cells and APCs against GzmB-inflicted damage. In this study, we used murine models to examine the previously unknown role of host-derived Spi6 in GVHD pathogenesis. Our results indicated that host Spi6 deficiency exacerbated GVHD as evidenced by significantly increased lethality, clinical and histopathological scores. Using bone marrow chimera system, we found that Spi6 in non-hematopoietic tissue played a dominant role in protecting against GVHD and was significantly upregulated in intestinal epithelial cells after allo-HCT, while Spi6 in hematopoietic APCs surprisingly suppressed alloreactive T cell response. Interestingly, the protective effect of Spi6 and its expression in intestinal epithelial cells appeared to be independent of donor-derived GzmB. We employed in silico modeling to explore potential targets of Spi6. Interaction tested in that could inhibit caspase-3 caspase-8 same functional loop an in vitro we T cell-derived inducing Spi6 expression in an intestinal epithelial cell line. our data indicate that host Spi6 plays a novel, GzmB-independent role in regulating alloreactive T cell response and protecting intestinal epithelial cells. Therefore, enhancing host-derived Spi6 function has the potential to reduce GVHD. in GVHD models, nor is known whether Spi6 can protect GVHD target cells such as intestinal epithelial cells. In this study, we have used several clinically relevant GVHD models to investigate the roles of Spi6 in host APCs and non-hematopoietic tissue cells. We have found that Spi6 deficiency in the host exacerbated GVHD. We demonstrate here that Spi6 plays important roles in host APC function and GVHD target organ protection in GzmB- independent manner. Using in silico methods we showed that Spi6 can inhibit caspase-3 and caspase-8 but with lower affinity compared to GzmB-Spi6 interaction. We confirmed that Spi6 expression and function in intestinal epithelial cells is dependent on donor T cell-derived IFN- γ . Altogether, our data suggest that Spi6 could have broader regulatory effect on inflammatory T cell response associated with GVHD that is beyond GzmB inhibition. provided by Dr. Dirk (Technische Universität München). This cell line was derived from C3H/He mice exhibits similar morphological and phenotypic characteristics of normal enterocytes as well as expressing MHC class II molecules and TLR9 23 . The cells were maintained at 37°C and 5% CO2 in DMEM high glucose supplemented with L-glutamine and 10% heat inactivated FBS. CD4+ and CD8+ cells were harvested from C57BL/6 mice by using EasySep mouse CD4+ isolation kit and EasySep CD8+ mouse isolation kit respectively (Stem Cells Technologies). MODE-K cells were cultured in 24-well plate. After 80% confluency, MODE-K cells were co-cultured with 2x10 5 either CD8+ T cells or CD4 + T cells in RPMI1640 culture media supplemented with L-glutamine, penicillin-streptomycin and 10% heat inactivated FBS. After 48 hours, cells were washed and MODE-K cells were detached using Trypsin and stained with live/dead, CD3 and Spi6 antibody. Spi6 protein was stained using rabbit anti mouse Spi6 antibody (Hycultbiotech) and Alexa-flour 488 donkey to rabbit IgG. CD3 and CD28 antibody (both form Bioxcell) were added in co-culture groups at 13μ/ml. Anti-mouse IFN- γ (clone H22; 53μ/ml) and purified Armenian hamster IgG isotype control (Clone HTK88; 53μ/ml) were used to block IFN- γ . To detect cytokine production by T cells in co-culture, we added Brefeldin A (Invitrogen) 4 hours before T cells staining. other criteria such as activity, severity of diarrhea and posture changes after consulting with veterinarian from animal facility. Statistical significances for Kaplan-Meier survival curves are evaluated by Log-rank (Mantel-Cox) tests and body weight loss, and clinical GVHD scores are evaluated

[1]  Kelvin P Lee,et al.  Serine protease inhibitor 6 protects alloreactive T cells from Granzyme B-mediated mitochondrial damage without affecting graft-versus-tumor effect , 2018, Oncoimmunology.

[2]  J. Ashwell,et al.  Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function , 2017, The Journal of Immunology.

[3]  R. Jenq,et al.  RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury , 2017, Science Translational Medicine.

[4]  Emily R. Levy,et al.  Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity , 2017, Nature Medicine.

[5]  A. Pourfathollah,et al.  Key role of Dkk3 protein in inhibition of cancer cell proliferation: An in silico identification. , 2016, Journal of theoretical biology.

[6]  R. Jenq,et al.  Interleukin-22 Promotes Intestinal Stem Cell-Mediated Epithelial Regeneration , 2015, Nature.

[7]  T. Brümmendorf,et al.  Telomere shortening in enterocytes of patients with uncontrolled acute intestinal graft-versus-host disease. , 2015, Blood.

[8]  Jingxin Qiu,et al.  Granzyme B–Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease , 2015, The Journal of Immunology.

[9]  J. Azzi,et al.  Serine Protease Inhibitor‐6 Differentially Affects the Survival of Effector and Memory Alloreactive CD8‐T Cells , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  S. Paczesny,et al.  Various Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation , 2014, Front. Immunol..

[11]  Taku Kambayashi,et al.  Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? , 2014, Nature Reviews Immunology.

[12]  R. Joshi,et al.  Resistance through inhibition: ectopic expression of serine protease inhibitor offers stress tolerance via delayed senescence in yeast cell. , 2014, Biochemical and biophysical research communications.

[13]  J. Azzi,et al.  Serine Protease Inhibitor 6 Plays a Critical Role in Protecting Murine Granzyme B–Producing Regulatory T Cells , 2013, The Journal of Immunology.

[14]  P. Ashton‐Rickardt An emerging role for Serine Protease Inhibitors in T lymphocyte immunity and beyond. , 2013, Immunology letters.

[15]  P. Bird,et al.  Serpinb9 (Spi6)‐deficient mice are impaired in dendritic cell‐mediated antigen cross‐presentation , 2012, Immunology and Cell Biology.

[16]  K. Wood,et al.  Regulatory immune cells in transplantation , 2012, Nature Reviews Immunology.

[17]  S. Gringhuis,et al.  Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome , 2012, Nature Immunology.

[18]  B. Malissen,et al.  Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease , 2011, Nature Medicine.

[19]  Hans Clevers,et al.  Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts , 2011, Nature.

[20]  D. Munn,et al.  Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. , 2010, Blood.

[21]  P. Ashton‐Rickardt,et al.  Serine Protease Inhibitor 6 Protects iNKT Cells from Self-Inflicted Damage , 2010, The Journal of Immunology.

[22]  P. Ashton‐Rickardt Serine protease inhibitors and cytotoxic T lymphocytes , 2010, Immunological reviews.

[23]  T. Rogers,et al.  The role of serpinb9/serine protease inhibitor 6 in preventing granzyme B–dependent hepatotoxicity , 2007, Hepatology.

[24]  T. Ley,et al.  Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. , 2007, Immunity.

[25]  J. Tschopp,et al.  Ectopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosis , 2007, Cell Death and Differentiation.

[26]  W. Shlomchik,et al.  Graft-versus-host disease , 2007, Nature Reviews Immunology.

[27]  Philip G Ashton-Rickardt,et al.  Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules. , 2006, Immunity.

[28]  R. Korngold,et al.  A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses , 2005, Nature Medicine.

[29]  E. Telemo,et al.  Human small intestinal epithelial cells constitutively express the key elements for antigen processing and the production of exosomes. , 2005, Blood cells, molecules & diseases.

[30]  Jiang Zhu,et al.  Alloreactive Memory T Cells Are Responsible for the Persistence of Graft-versus-Host Disease1 , 2005, The Journal of Immunology.

[31]  Christopher J. Froelich,et al.  A Role for the Granzyme B Inhibitor Serine Protease Inhibitor 6 in CD8+ Memory Cell Homeostasis1 , 2004, The Journal of Immunology.

[32]  D. Jain,et al.  Donor APCs are required for maximal GVHD but not for GVL , 2004, Nature Medicine.

[33]  M. Abougergi,et al.  Antiviral Cytokines Induce Hepatic Expression of the Granzyme B Inhibitors, Proteinase Inhibitor 9 and Serine Proteinase Inhibitor 61 , 2004, The Journal of Immunology.

[34]  T. Schumacher,et al.  Expression of the Serpin Serine Protease Inhibitor 6 Protects Dendritic Cells from Cytotoxic T Lymphocyte–Induced Apoptosis , 2001, The Journal of experimental medicine.

[35]  J. Mankovich,et al.  Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. , 1999, The Biochemical journal.

[36]  M. Shlomchik,et al.  Prevention of graft versus host disease by inactivation of host antigen-presenting cells. , 1999, Science.

[37]  R. Hershberg,et al.  Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. , 1997, The Journal of clinical investigation.

[38]  J. Revillard,et al.  Immortalization of mouse intestinal epithelial cells by the SV40-large T gene. Phenotypic and immune characterization of the MODE-K cell line. , 1993, Journal of immunological methods.